Nuzenio

Transthera Sciences Yochanra

Transthera Sciences Yochanra news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 7 publisher sources 100/100 entity strength

Latest news

China approval for TransThera’s Yochanra - The Pharma LetterThe Pharma Letter · Fri, 07 Aug 2026 19:24:48 GMT China approves therapy tackling FGFR inhibitor resistance in biliary cancer - FirstWord PharmaFirstWord Pharma · Fri, 07 Aug 2026 13:02:10 GMT Yochanra® approved in China as world-first for FGFR inhibitor-resistant cancer - European Pharmaceutical ReviewEuropean Pharmaceutical Review · Fri, 07 Aug 2026 12:25:36 GMT TransThera's resistant biliary cancer drug cleared in China - pharmaphorumpharmaphorum · Fri, 07 Aug 2026 11:50:30 GMT TransThera Sciences Yochanra Receives Approval For Marketing In China And Presents Phase II Clinical Trial Results - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 06:44:00 GMT TransThera Wins First China Approval for Yochanra in Advanced Cholangiocarcinoma - TipRanksTipRanks · Fri, 07 Aug 2026 05:38:49 GMT TransThera wins first China approval in post-FGFR cholangiocarcinoma - AllSciAllSci · Thu, 06 Aug 2026 16:41:13 GMT

Timeline

Fri, 07 Aug 2026 19:24:48 GMTChina approval for TransThera’s Yochanra - The Pharma Letter

Fri, 07 Aug 2026 13:02:10 GMTChina approves therapy tackling FGFR inhibitor resistance in biliary cancer - FirstWord Pharma

Fri, 07 Aug 2026 12:25:36 GMTYochanra® approved in China as world-first for FGFR inhibitor-resistant cancer - European Pharmaceutical Review

Fri, 07 Aug 2026 11:50:30 GMTTransThera's resistant biliary cancer drug cleared in China - pharmaphorum

Fri, 07 Aug 2026 06:44:00 GMTTransThera Sciences Yochanra Receives Approval For Marketing In China And Presents Phase II Clinical Trial Results - marketscreener.com

Fri, 07 Aug 2026 05:38:49 GMTTransThera Wins First China Approval for Yochanra in Advanced Cholangiocarcinoma - TipRanks

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

China9 live mentions FGFR6 live mentions TransThera5 live mentions Yochanra5 live mentions European Pharmaceutical Review3 live mentions Receives Approval For2 live mentions Marketing In China2 live mentions And Presents Phase2 live mentions II Clinical Trial2 live mentions Results2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Transthera Sciences Yochanra.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.